Anti c-Myc Tag scFv (Clone 9E10), His Tag | PA000002.scFv
$900.00 – $1,500.00
Ultra-compact recombinant anti c-myc antibody (Clone 9E10 scFv) engineered with a C-terminal His-tag for high-affinity, Fc-free detection of EQKLISEEDL-tagged proteins. The ~27 kDa single-chain format eliminates Fc background and improves intracellular and structural penetration.
- Details & Specifications
- References
- Other Formats
- Ushelf Advisor
| Catalog No. | PA000002.scFv |
|---|---|
| Product Name | Recombinant Anti-Myc-Tag scFv (clone 9E10), His Tag |
| Data Sheet | 📄 Download Product Data Sheet (PDF) |
| Supplier Name | Syd Labs, Inc. |
| Brand Name | Syd Labs |
| Synonyms | Anti-c-Myc Antibody, c-Myc Antibody (9E10), Clone 9E10 |
| Summary | The recombinant anti-Myc-Tag mouse IgG1 monoclonal antibody (clone 9E10) is produced in mammalian cells. It consists of mouse variable regions and mouse IgG1 kappa constant regions. |
| Clone | 9E10 |
| Specificity/Sensitivity | c-Myc tagged proteins and Myc tag expression cells. |
| Applications | ELISA, flow cytometry, immunoblotting, immunoprecipitation, immunocytochemistry, immunofluorescence, chromatin immunoprecipitation, electron microscopy, supershift assays, protein purification if conjugated with agarose or magnetic beads, and isotype controls. |
| Reactivity | Human, Mouse, Rat, Others. |
| Purification | The c-Myc-tag antibody was affinity-purified from supernatant of mammalian cells cultured in a chemically defined medium by affinity-chromatography using protein A. |
| Form Of Antibody | 1 mg/ml in 1x PBS. |
| Purity | >95% by SDS-PAGE under reducing conditions. |
| Shipping | The recombinant anti-Myc-Tag mouse IgG1 monoclonal antibody (clone 9E10) is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. For maximum recovery of the product, centrifuge the original vial after thawing and before removing the cap. 1 month from date of receipt, 2 to 8°C as supplied. 3 months from date of receipt, -20°C to -70°C as supplied. |
| Note | Recombinant Myc-Tag monoclonal antibodies (clone 9E10) with various isotypes; low prices for bulk order. |
| Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Or leave a message with a formal purchase order (PO) Or credit card. |
Description
Recombinant Anti-Myc-Tag scFv (Clone 9E10) is an engineered, sequence-defined single-chain variable fragment consisting of the heavy and light chain variable domains of the legendary 9E10 hybridoma connected by a flexible peptide linker, fused with a C-terminal His-tag. Designed to specifically target the canonical 10-amino-acid c-Myc epitope tag (EQKLISEEDL, residues 410–419 of human c-Myc, UniProt ID: P01106), this anti c-myc antibody format provides exceptional biochemical performance for advanced life science applications.
At approximately 27 kDa, this Fc-free single-chain format completely eliminates non-specific Fc receptor binding and avoids receptor cross-linking during live-cell or immunological workflows. Furthermore, its ultra-small molecular weight facilitates superior cellular and tissue penetration, making it an indispensable reagent for structural biology studies, high-resolution co-immunoprecipitation (Co-IP), and intracellular probing without heavy or light chain shadow bands.
Key Product Highlights
- Ultra-Compact scFv Format (~27 kDa): Lacks the Fc domain entirely, eliminating FcR-mediated background on immune cells and avoiding Protein A/G resin interference.
- C-Terminal His-Tag Incorporation: Enables dual-mode detection and downstream affinity verification using anti-His tag reagents.
- Gold-Standard 9E10 Specificity: Recognizes the linear EQKLISEEDL epitope at either the N- or C-terminus of fusion constructs.
- Sequence-Defined Recombinant Consistency: Recombinant mammalian production guarantees absolute lot-to-lot reproducibility and high purity (>95% by SDS-PAGE).
References of Anti c-Myc Tag Monoclonal Antibody (Clone 9E10)
1. Truncated mini LRP1 transports cargo from luminal to basolateral side across the blood brain barrier
Laura Fritzen, et al. Fluids Barriers CNS. 2024 Sep 17;21(1):74. doi: 10.1186/s12987-024-00573-1. PMID: 39289695; PMCID: PMC11409491
“Transporting drugs across the blood-brain barrier (BBB) remains a major challenge in developing central nervous system (CNS) therapies. While previous research has utilized nanoparticle formulations to target BBB receptors, the precise mechanisms governing their entry and distribution within the CNS parenchyma are largely unexplored. This study investigates the novel pathways facilitating therapeutic cargo movement from the luminal to the basolateral side of the BBB.”
2. Structural basis for human Cav3.2 inhibition by selective antagonists
Jian Huang, et al. Cell Res. 2024 Feb;34(2):162-171. doi: 10.1038/s41422-023-00917-w. PMID: 38212423; PMCID: PMC10858654
“Low-voltage-activated T-type calcium channels, particularly Cav3.2, play critical roles in neuronal excitability, pain signaling, and cardiac pacemaking. Despite their physiological importance, the structural mechanisms underlying selective pharmacological inhibition of Cav3.2 remain poorly understood. Using cryo-electron microscopy, researchers determined high-resolution structures of human Cav3.2 bound to selective blockers, revealing key conformational rearrangements and binding pocket determinants for targeted drug design.”
3. Molecular mechanism of human P-glycoprotein-mediated substrate transport
Amer Alam, et al. Nature. 2023 Jul;619(7971):880-886. doi: 10.1038/s41586-023-06332-w. PMID: 37438527; PMCID: PMC10333199
“P-glycoprotein (ABCB1) is an ATP-binding cassette transporter that mediates the efflux of diverse hydrophobic compounds across cellular membranes, contributing significantly to multidrug resistance in cancer chemotherapy. However, the conformational dynamics coupling substrate translocation to ATP hydrolysis have remained elusive. High-resolution cryo-EM structures of Myc-tagged human ABCB1 in distinct functional states illuminate the molecular basis of substrate recognition and vectorial transport.”
4. Cryo-EM structures of the human endolysosomal TRPML3 channel in closed and open states
Min Woo Kim, et al. Nat Struct Mol Biol. 2023 Feb;30(2):183-192. doi: 10.1038/s41594-022-00911-2. PMID: 36658365; PMCID: PMC9905012
“TRPML3 is an endolysosomal cation channel essential for membrane trafficking, autophagy, and intracellular calcium homeostasis. To elucidate how luminal pH and phosphoinositides regulate channel gating, researchers purified Myc-tagged TRPML3 complexes and resolved their three-dimensional architectures. The structural comparisons uncover an allosteric gating mechanism that controls ion permeation across endolysosomal membranes.”
5. Mechanisms of human mitochondrial RNA polymerase transcription initiation and promoter escape
Hauke S. Hillen, et al. Mol Cell. 2022 Feb 3;82(3):561-574.e6. doi: 10.1016/j.molcel.2021.12.012. PMID: 34995508; PMCID: PMC8816375
“Transcription of the human mitochondrial genome is executed by a single-subunit mitochondrial RNA polymerase (POLRMT) in coordination with auxiliary initiation factors. How POLRMT transitions from initial promoter recognition to processive RNA elongation has not been fully resolved. Biochemical and structural analyses of affinity-tagged transcription complexes reveal the step-by-step conformational transitions required for promoter melting and RNA synthesis.”
For more technical references or data sheets regarding the Anti-Myc-Tag Monoclonal Antibody (Clone 9E10) formats, please contact our scientific support team at message@sydlabs.com.
Other Tag Antibodies:
His-tag Monoclonal Antibody
GFP-tag Monoclonal Antibody
RFP-tag Monoclonal Antibody
HA-tag Monoclonal Antibody
DYKDDDDK-tag Monoclonal Antibody
V5-tag Monoclonal Antibody
Other Formats
All variants below share identical Clone 9E10 variable region sequences and high-affinity binding specificity toward the c-Myc epitope tag (EQKLISEEDL). They differ in antibody format, species constant region (isotype), and valency — choose the format that best matches your secondary antibody compatibility, species background, and experimental readout.
| Catalog No. | Format / Isotype | Valency / Fc Status | Host / Reactivity | Applications & Key Advantages |
|---|---|---|---|---|
| PA000002.m1 | Mouse IgG1, kappa | Bivalent / Intact Mouse Fc | Mouse / Myc-tag | Standard WB, IP, IF, FCM, and ELISA; matches original hybridoma 9E10 isotype with superior recombinant consistency. |
| PA000002.mf | Mouse Fab Fragment | Monovalent / Fc-Free | Mouse / Myc-tag | Zero FcR background on immune cells; no Protein A/G binding; prevents target dimerization; ideal for cryo-EM & live-cell imaging. |
| PA000002.scFv | scFv Fragment, His-Tagged | Monovalent / Fc-Free (~27 kDa) | Recombinant / Myc-tag | Ultra-compact size for high tissue penetration; C-terminal His-tag for anti-His detection/purification; structural studies. |
| PA000002.h1 | Human IgG1, kappa | Bivalent / Intact Human Fc | Human / Myc-tag | Avoids anti-mouse secondary cross-reactivity in murine tissues; ideal control for human-format assays. |
| PA000002.rt | Rabbit IgG | Bivalent / Intact Rabbit Fc | Rabbit / Myc-tag | Multiplexed IF/WB co-staining alongside mouse primary antibodies without secondary antibody cross-reactivity. |
How to choose a format for your Myc-tag assay: For routine Western Blot, IP, and ELISA using standard secondary antibodies, PA000002.m1 (Mouse IgG1) is the standard reference. When staining murine tissues or avoiding anti-mouse cross-reactivity, choose PA000002.rt (Rabbit IgG) or PA000002.h1 (Human IgG1). For immune cell flow cytometry or structural cryo-EM complexes, use the Fc-free PA000002.mf (Mouse Fab) format. For maximum intracellular penetration, structural analysis, or His-tag affinity compatibility, choose the ultra-compact PA000002.scFv (His-tagged scFv) format.
Ushelf Advisor
Technical Reference Note: These answers are compiled from peer-reviewed literature and Ushelf product validation data, and reviewed by our scientific support team. They are provided for general research reference only—please verify critical experimental parameters (such as working dilutions, buffer conditions, and His-tag detection methods) against primary references or contact our technical support before finalizing your protocol. Last updated: November 2026.
Q: What is the main structural advantage of using a Recombinant Anti-Myc-Tag scFv (Clone 9E10) over a full-length IgG antibody?
The primary structural advantage of a single-chain variable fragment (scFv) is its ultra-compact size (~27 kDa) and complete absence of the immunoglobulin Fc domain. While conventional full-length anti c-myc antibodies contain constant Fc regions that can cause high non-specific background via Fc receptor binding on immune cells (macrophages, monocytes) or bind to Protein A/G beads during immunoprecipitation, the scFv format eliminates Fc-mediated interference. This makes the anti-myc scFv ideal for complex co-immunoprecipitations, live-cell tracking without receptor cross-linking, and applications requiring high tissue penetration.
Q: How does the C-terminal His-tag on this scFv fragment assist in experimental detection and purification?
The engineered C-terminal His-tag (typically a 6xHis or polyhistidine sequence) on PA000002.scFv serves a dual purpose. First, it allows researchers to verify expression or detect the primary antibody in specialized multi-color or multiplex assays using anti-His tag secondary reagents or conjugated anti-His antibodies. Second, it facilitates straightforward quantification and potential affinity cleanup during complex reconstitution, ensuring robust quality control in demanding structural and biochemical workflows.
Q: Why does my anti c-myc antibody (Clone 9E10 scFv) show weak or absent signals in Western Blot (WB)?
Weak detection in Western Blotting when using an scFv format is usually attributable to epitope masking, suboptimal transfer conditions, or choice of secondary detection reagents. Because scFv fragments lack an Fc region, standard anti-mouse Fc secondary antibodies will not work; you must use an anti-His tag antibody or a tag-specific reagent for visualization. Additionally, ensure that your fusion protein incorporates a flexible linker (e.g., GGGGS) between the protein of interest and the Myc tag to prevent steric burial within folded domains, and verify complete sample denaturation with reducing agents.
Q: Can clone 9E10 scFv recognize c-Myc tags placed at either the N-terminus or C-terminus?
Yes. Clone 9E10 specifically recognizes the linear 10-amino-acid peptide sequence EQKLISEEDL, which retains high immunogenicity and accessibility at both terminal positions of recombinant fusion proteins. While C-terminal tagging closely mimics the native orientation of human c-Myc, N-terminal tagging is equally effective provided that bulky or charged residues are not positioned directly adjacent to the initial Glutamic acid (E) to avoid steric hindrance.
Q: What are the recommended starting dilutions for this scFv antibody in Western Blot and Immunofluorescence?
Due to the monovalent and compact nature of scFv fragments, starting dilutions should be optimized empirically based on target expression abundance. General guidelines for PA000002.scFv (1 mg/mL stock) include: 1 to 2 µg/mL (1:500 to 1:1,000 dilution) for Western Blot (WB); 2 to 5 µg/mL for Immunofluorescence (IF) and Flow Cytometry (FCM); and 1 to 3 µg per assay for Immunoprecipitation (IP) when paired with appropriate capture methods.




